Identification
- Summary
Anthoxanthum odoratum pollen is an extract from Anthoxanthum odoratum pollen used in allergy testing.
- Brand Names
- Oralair 100, Oralair 300, Oralair Children and Adolescents Sample Kit
- Generic Name
- Anthoxanthum odoratum pollen
- DrugBank Accession Number
- DB10404
- Background
Anthoxanthum odoratum pollen is the pollen of the Anthoxanthum odoratum plant. Anthoxanthum odoratum pollen is mainly used in allergenic testing.
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Allergenics
Allergen Extract - Synonyms
- Standardized sweet vernal grass pollen
- Sweet vernal grass pollen extract
Pharmacology
- Indication
Anthoxanthum odoratum pollen is an allergen extract included in an allergenic testing product called ORALAIR. It is indicated as immunotherapy for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis confirmed by positive skin test or in vitro testing for pollen38 specific IgE antibodies for any of the five grass species contained in this product. ORALAIR is approved for use in persons 5 through 65 years of age.1
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Used in combination for diagnostic process Allergic rhinitis due to pollen •••••••••••• Used in combination for diagnostic process Allergic rhinitis due to pollen •••••••••••• •••••••••••••• - Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAcebutolol The risk of a hypersensitivity reaction to Anthoxanthum odoratum pollen is increased when it is combined with Acebutolol. Atenolol The risk of a hypersensitivity reaction to Anthoxanthum odoratum pollen is increased when it is combined with Atenolol. Benazepril The risk or severity of adverse effects can be increased when Benazepril is combined with Anthoxanthum odoratum pollen. Betaxolol The risk of a hypersensitivity reaction to Anthoxanthum odoratum pollen is increased when it is combined with Betaxolol. Bisoprolol The risk of a hypersensitivity reaction to Anthoxanthum odoratum pollen is increased when it is combined with Bisoprolol. - Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Allergenic Extract - Standardized Grass Pollen - Sweet Vernal Liquid 100000 unit / mL Intradermal; Subcutaneous Greer Laboratories 2000-10-30 Not applicable Canada 
Allergenic Extract - Standardized Grass Pollen - Sweet Vernal Liquid 10000 unit / mL Intradermal; Subcutaneous Greer Laboratories 2023-02-22 Not applicable Canada Allergenic Extract - Standardized Sweet Vernal Grass Pollen Liquid 100000 unit / mL Intradermal; Percutaneous; Subcutaneous Alk Abello, Inc. 2009-07-30 Not applicable Canada Oralair Tablet 100 [IR] Sublingual Stallergenes Canada Inc 2012-07-26 Not applicable Canada Oralair Tablet 300 [IR] Sublingual Stallergenes Canada Inc 2012-07-26 Not applicable Canada - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image 5 Grass Mix Anthoxanthum odoratum pollen (10000 [PNU]/1mL) + Agrostis gigantea pollen (10000 [PNU]/1mL) + Dactylis glomerata pollen (10000 [PNU]/1mL) + Phleum pratense pollen (10000 [PNU]/1mL) + Poa pratensis pollen (10000 [PNU]/1mL) Injection, solution Subcutaneous ALK-Abello, Inc. 1975-01-15 2023-05-25 US 
5 Grass Mix Anthoxanthum odoratum pollen (5000 [PNU]/1mL) + Agrostis gigantea pollen (5000 [PNU]/1mL) + Dactylis glomerata pollen (5000 [PNU]/1mL) + Phleum pratense pollen (5000 [PNU]/1mL) + Poa pratensis pollen (5000 [PNU]/1mL) Injection, solution Subcutaneous ALK-Abello, Inc. 1975-01-15 2023-05-25 US 5 Grass Mix Anthoxanthum odoratum pollen (100 [PNU]/1mL) + Agrostis gigantea pollen (100 [PNU]/1mL) + Dactylis glomerata pollen (100 [PNU]/1mL) + Phleum pratense pollen (100 [PNU]/1mL) + Poa pratensis pollen (100 [PNU]/1mL) Injection, solution Subcutaneous ALK-Abello, Inc. 1975-01-15 2023-05-24 US 5 Grass Mix Anthoxanthum odoratum pollen (1000 [PNU]/1mL) + Agrostis gigantea pollen (1000 [PNU]/1mL) + Dactylis glomerata pollen (1000 [PNU]/1mL) + Phleum pratense pollen (1000 [PNU]/1mL) + Poa pratensis pollen (1000 [PNU]/1mL) Injection, solution Subcutaneous ALK-Abello, Inc. 1975-01-15 2023-05-25 US 7 Standardized Grass Pollen Mix Anthoxanthum odoratum pollen (1428.5714 [BAU]/1mL) + Agrostis gigantea pollen (1428.5714 [BAU]/1mL) + Dactylis glomerata pollen (1428.5714 [BAU]/1mL) + Festuca pratensis pollen (1428.5714 [BAU]/1mL) + Lolium perenne pollen (1428.5714 [BAU]/1mL) + Phleum pratense pollen (1428.5714 [BAU]/1mL) + Poa pratensis pollen (1428.5714 [BAU]/1mL) Solution Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1968-09-15 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 2KIK19R45Y
- CAS number
- Not Available
References
- General References
- FDA Approved Drug Products: ORALAIR 6 (Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass Mixed Pollens Allergen Extract) Tablet for Sublingual Use [Link]
- External Links
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 3 Completed Treatment Allergic Reaction 1 Not Available Completed Not Available Allergic Reaction 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, solution Subcutaneous Solution Intradermal; Percutaneous; Subcutaneous Liquid Intradermal; Percutaneous; Subcutaneous Liquid Intradermal; Subcutaneous 10000 unit / mL Liquid Intradermal; Subcutaneous 100000 unit / mL Liquid Intradermal; Percutaneous; Subcutaneous 100000 unit / mL Liquid Subcutaneous Kit Sublingual Kit; tablet, orally disintegrating Sublingual Tablet Sublingual 100 [IR] Tablet Sublingual 300 [IR] Tablet, orally disintegrating Sublingual Injection, solution Percutaneous Tablet Sublingual Solution Percutaneous; Subcutaneous 100000 unit Injection, solution Intradermal Injection, solution Percutaneous; Subcutaneous Injection, solution Intradermal 100 [BAU]/1mL Injection, solution Intradermal 1000 [BAU]/1mL Injection, solution Percutaneous; Subcutaneous 10000 [BAU]/1mL Injection Cutaneous; Intradermal; Subcutaneous 100000 [BAU]/1mL Injection, solution Intradermal; Subcutaneous 10000 [BAU]/1mL Injection, solution Intradermal; Subcutaneous 100000 [BAU]/1mL Injection, solution Percutaneous; Subcutaneous 100000 [BAU]/1mL Solution Intradermal; Percutaneous; Subcutaneous 10000 [BAU]/1mL Solution Intradermal; Percutaneous; Subcutaneous 100000 [BAU]/1mL Injection, solution Subcutaneous 10000 [BAU]/1mL Injection, solution Subcutaneous 100000 [BAU]/1mL Solution Percutaneous 10000 [BAU]/1mL Solution Percutaneous 100000 [BAU]/1mL Injection, solution Intradermal; Subcutaneous - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 01, 2015 20:03 / Updated at April 24, 2024 14:30